Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015 (2015), Article ID 934380, 8 pages
http://dx.doi.org/10.1155/2015/934380
Review Article

Towards Multidimensional Radiotherapy: Key Challenges for Treatment Individualisation

1Medical Radiation Physics, Stockholm University and Karolinska Institutet, P.O. Box 260, 171 76 Stockholm, Sweden
2Department of Radiation Physics and Department of Medical and Health Sciences, Linköping University, 581 83 Linköping, Sweden

Received 4 July 2014; Accepted 3 September 2014

Academic Editor: Eva Bezak

Copyright © 2015 Iuliana Toma-Dasu and Alexandru Dasu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Ling, J. Humm, S. Larson et al., “Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 3, pp. 551–560, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Apisarnthanarax and K. S. C. Chao, “Current imaging paradigms in radiation oncology,” Radiation Research, vol. 163, no. 1, pp. 1–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Brahme, “Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging,” Acta Oncologica, vol. 42, no. 2, pp. 123–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Bentzen, “Theragnostic imaging for radiation oncology: dose-painting by numbers,” The Lancet Oncology, vol. 6, no. 2, pp. 112–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nordsmark, M. Overgaard, and J. Overgaard, “Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck,” Radiotherapy and Oncology, vol. 41, no. 1, pp. 31–39, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, “Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck,” International Journal of Radiation Oncology Biology Physics, vol. 38, no. 2, pp. 285–289, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Overgaard, “Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors,” Oncology Research, vol. 6, no. 10-11, pp. 509–518, 1994. View at Google Scholar · View at Scopus
  8. P. Vaupel and A. Mayer, “Hypoxia in cancer: significance and impact on clinical outcome,” Cancer and Metastasis Reviews, vol. 26, no. 2, pp. 225–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. S. C. Chao, W. R. Bosch, S. Mutic et al., “A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy,” International Journal of Radiation Oncology Biology Physics, vol. 49, no. 4, pp. 1171–1182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A.-L. Grosu, M. Souvatzoglou, B. Röper et al., “Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer,” International Journal of Radiation Oncology Biology Physics, vol. 69, no. 2, pp. 541–551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. T. Lee and A. M. Scott, “Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole,” Seminars in Nuclear Medicine, vol. 37, no. 6, pp. 451–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Alber, F. Paulsen, S. M. Eschmann, and H. J. Machulla, “On biologically conformal boost dose optimization,” Physics in Medicine and Biology, vol. 48, no. 2, pp. N31–N35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. K. Das, M. M. Miften, S. Zhou et al., “Feasebility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions,” Medical Physics, vol. 31, no. 6, pp. 1452–1461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Malinen, A. Søvik, D. Hristov, O. S. Bruland, and D. R. Olsen, “Adapting radiotherapy to hypoxic tumours,” Physics in Medicine and Biology, vol. 51, no. 19, pp. 4903–4921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. T. Flynn, S. R. Bowen, S. M. Bentzen, T. R. Mackie, and R. Jeraj, “Intensity-modulated X-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting,” Physics in Medicine and Biology, vol. 53, no. 15, pp. 4153–4167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Thorwarth, S.-M. Eschmann, F. Paulsen, and M. Alber, “Hypoxia dose painting by numbers: a planning study,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 1, pp. 291–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Roels, P. Slagmolen, J. Nuyts et al., “Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?” Acta Oncologica, vol. 47, no. 7, pp. 1237–1248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Toma-Daşu, A. Daşu, and A. Brahme, “Dose prescription and optimisation based on tumour hypoxia,” Acta Oncologica, vol. 48, no. 8, pp. 1181–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Toma-Dasu, J. Uhrdin, L. Antonovic et al., “Dose prescription and treatment planning based on FMISO-PET hypoxia,” Acta Oncologica, vol. 51, no. 2, pp. 222–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. R. Whithers, J. M. G. Taylor, and B. Maciejewski, “The hazard of accelerated tumor clonogen repopulation during radiotherapy,” Acta Oncologica, vol. 27, no. 2, pp. 131–146, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Vaupel, F. Kallinowski, and P. Okunieff, “Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review,” Cancer Research, vol. 49, no. 23, pp. 6449–6465, 1989. View at Google Scholar · View at Scopus
  22. V. Gregoire, “Is there any future in radiotherapy planning without the use of PET: unraveling the myth,” Radiotherapy and Oncology, vol. 73, no. 3, pp. 261–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Schwartz, E. C. Ford, J. Rajendran et al., “FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation,” Head and Neck, vol. 27, no. 6, pp. 478–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Grégoire and A. Chiti, “Molecular imaging in radiotherapy planning for head and neck tumors,” Journal of Nuclear Medicine, vol. 52, no. 3, pp. 331–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Ho, S. C. H. Yu, and D. W. Yeung, “11C-acetate PET imaging in hepatocellular carcinoma and other liver masses,” Journal of Nuclear Medicine, vol. 44, no. 2, pp. 213–221, 2003. View at Google Scholar · View at Scopus
  26. G. Sandblom, J. Sörensen, N. Lundin, M. Häggman, and P.-U. Malmström, “Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy,” Urology, vol. 67, no. 5, pp. 996–1000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Sun, J. Sörensen, M. Karlsson et al., “1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 5, pp. 651–657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Sun, S. Johansson, I. Turesson, A. Dau, and J. Sörensen, “Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1-[11C]-acetate PET during radiotherapy: preliminary results,” International Journal of Radiation Oncology Biology Physics, vol. 82, no. 2, pp. 554–560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dasu, “Treatment planning optimisation based on imaging tumour proliferation and cell density,” Acta Oncologica, vol. 47, no. 7, pp. 1221–1228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. H. Chadwick and H. P. Leenhouts, “A molecular theory of cell survival,” Physics in Medicine and Biology, vol. 18, no. 1, pp. 78–87, 1973. View at Publisher · View at Google Scholar · View at Scopus
  31. B. G. Douglas and J. F. Fowler, “Fractionation schedules and a quadratic dose effect relationship,” British Journal of Radiology, vol. 48, no. 570, pp. 502–504, 1975. View at Publisher · View at Google Scholar · View at Scopus
  32. G. W. Barendsen, “Dose fraction, dose rate and iso-effect relationships for normal tissue responses,” International Journal of Radiation Oncology Biology Physics, vol. 8, no. 11, pp. 1981–1997, 1982. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. Fowler, “The linear-quadratic formula and progress in fractionated radiotherapy,” British Journal of Radiology, vol. 62, no. 740, pp. 679–694, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Alper and P. Howard-Flanders, “Role of oxygen in modifying the radiosensitivity of E. coli B,” Nature, vol. 178, no. 4540, pp. 978–979, 1956. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Meijer, J. Steenhuijsen, M. Bal, K. De Jaeger, D. Schuring, and J. Theuws, “Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush,” Radiotherapy and Oncology, vol. 100, no. 3, pp. 396–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. K. Buck, G. Halter, H. Schirrmeister et al., “Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG,” Journal of Nuclear Medicine, vol. 44, no. 9, pp. 1426–1431, 2003. View at Google Scholar · View at Scopus
  37. D. L. Francis, A. Freeman, D. Visvikis et al., “In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography,” Gut, vol. 52, no. 11, pp. 1602–1606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Toma-Dasu, J. Uhrdin, A. Dasu, and A. Brahme, “Therapy optimization based on non-linear uptake of PET tracers versus ‘linear dose painting’,” IFMBE Proceedings I, vol. 25, pp. 221–224, 2009. View at Google Scholar
  39. I. Toma-Dasu and A. Dasu, “Biologically-optimised IMRT based on molecular imaging of tumour hypoxia-the impact of the tracer used,” IFMBE Proceedings, vol. 39, pp. 1742–1745, 2013. View at Publisher · View at Google Scholar
  40. P. Vera, P. Bohn, A. Edet-Sanson et al., “Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18F-fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study,” Radiotherapy and Oncology, vol. 98, no. 1, pp. 109–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. J. Bradshaw, S. Yip, N. Jallow, L. J. Forrest, and R. Jeraj, “Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy,” International Journal of Radiation Oncology Biology Physics, vol. 89, no. 2, pp. 399–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Daşu, I. Toma-Dasu, and J. F. Fowler, “Should single or distributed parameters be used to explain the steepness of tumour control probability curves?” Physics in Medicine and Biology, vol. 48, no. 3, pp. 387–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Hedman, T. Bjork-Eriksson, O. Brodin, and I. Toma-Dasu, “Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time,” British Journal of Radiology, vol. 86, no. 1025, Article ID 20130015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Bauer, D. Unholtz, F. Sommerer et al., “Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment,” Radiotherapy and Oncology, vol. 107, no. 2, pp. 218–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Frey, J. Bauer, D. Unholtz et al., “TPS(PET): a TPS-based approach for in vivo dose verification with PET in proton therapy,” Physics in Medicine and Biology, vol. 59, no. 1, pp. 1–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. T. E. Schultheiss, W. A. Tome, and C. G. Orton, “Point/counterpoint: it is not appropriate to “deform” dose along with deformable image registration in adaptive radiotherapy,” Medical Physics, vol. 39, no. 11, pp. 6531–6533, 2012. View at Google Scholar
  47. E. Brun, E. Kjellen, J. Tennvall et al., “FDG pet studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma,” Head and Neck, vol. 24, no. 2, pp. 127–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. A. van Baardwijk, G. Bosmans, A. Dekker et al., “Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients,” Radiotherapy and Oncology, vol. 82, no. 2, pp. 145–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Hentschel, S. Appold, A. Schreiber et al., “Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 7, pp. 1203–1211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Massaccesi, M. L. Calcagni, M. G. Spitilli et al., “18F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose,” Radiation Oncology, vol. 7, article 106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. W. van Elmpt, M. Öllers, A.-M. C. Dingemans, P. Lambin, and D. de Ruysscher, “Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer,” Journal of Nuclear Medicine, vol. 53, no. 10, pp. 1514–1520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. J. K. Hoang, S. K. Das, K. R. Choudhury, D. S. Yoo, and D. M. Brizel, “Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change,” The American Journal of Neuroradiology, vol. 34, no. 7, pp. 1428–1433, 2013. View at Google Scholar
  53. E. A. Usmanij, L. F. de Geus-Oei, E. G. C. Troost et al., “18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy,” Journal of Nuclear Medicine, vol. 54, no. 9, pp. 1528–1534, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Toma-Dasu, J. Uhrdin, A. Dasu, S. Carvalo, W. van Elmpt, and P. Lambin, “Evaluating tumour response of NSCLC patients with FDG-PET: potential for treatment individualisation,” Radiotherapy and Oncology, vol. 111, supplement 1, p. 364, 2014. View at Google Scholar
  55. J. G. Rajendran, D. L. Schwartz, J. O'Sullivan et al., “Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer,” Clinical Cancer Research, vol. 12, no. 18, pp. 5435–5441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. J. van Loon, A. van Baardwijk, L. Boersma, M. Öllers, P. Lambin, and D. de Ruysscher, “Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer,” Cancer Treatment Reviews, vol. 37, no. 5, pp. 331–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Quon and D. M. Brizel, “Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas,” Seminars in Radiation Oncology, vol. 22, no. 3, pp. 220–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. H. J. W. L. Aerts, J. Bussink, W. J. G. Oyen et al., “Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation,” Lung Cancer, vol. 75, no. 1, pp. 73–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Inubushi, T. Saga, M. Koizumi et al., “Predictive value of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma,” Annals of Nuclear Medicine, vol. 27, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. D. L. Hill, P. G. Batchelor, M. Holden, and D. J. Hawkes, “Medical image registration,” Physics in Medicine and Biology, vol. 46, no. 3, pp. R1–45, 2001. View at Google Scholar
  61. D. Tilly, N. Tilly, and A. Ahnesjo, “Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy: applied to prostate proton treatments,” BMC Medical Physics, vol. 13, article 2, no. 1, 2013. View at Publisher · View at Google Scholar
  62. H. C. Thoeny and B. D. Ross, “Predicting and monitoring cancer treatment response with diffusion-weighted MRI,” Journal of Magnetic Resonance Imaging, vol. 32, no. 1, pp. 2–16, 2010. View at Google Scholar
  63. T. Nielsen, T. Wittenborn, and M. R. Horsman, “Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in preclinical studies of antivascular treatments,” Pharmaceutics, vol. 4, no. 4, pp. 563–589, 2012. View at Google Scholar
  64. A. Dasu and I. Toma-Dasu, “Vascular oxygen content and the tissue oxygenation: a theoretical analysis,” Medical Physics, vol. 35, no. 2, pp. 539–545, 2008. View at Google Scholar